Condition: Breast Cancer · Breast Neoplasms · Sponsor: Pfizer
The purpose of this clinical study is to learn about the safety and effects of the study medicine (called disitamab vedotin) for the possible treatment of people with breast cancer that is hard to treat and has spread in the body (advanced cancer). This study is seeking participants who: * have breast cancer that is hard to treat and has spread in the body (advanced cancer) * have tumors that have HER2 on them * have received previous treatment for their advanced breast cancer All participants in this study will receive disitamab vedotin at the study clinic once every 2 weeks as an intravenous (IV) infusion (given directly into a vein). Participants will take the study medicine until they or their doctor decides to stop. This might be because their cancer is getting worse, the study medicine is no longer helping, they have bad side effects, or they wish to stop taking the study medicine. During this time, the participants will have study visits every 2 weeks. After the participants have stopped taking the study medicine, they will have follow-up visits about every 6 weeks unless their cancer gets worse. After that, they will have follow-up phone calls about every 12 weeks. The study team will look at the experiences of people receiving the study medicine. This will help the study team decide if the study medicine is safe and effective.
This description comes directly from the study's public registry record.
Pfizer CT.gov Call Center · 1-800-718-1021 · ClinicalTrials.gov_Inquiries@pfizer.com
Always discuss trial participation with your own doctor first.
| Southern Cancer Center, PC | Daphne, Alabama, United States | Recruiting |
| Southern Cancer Center, PC | Foley, Alabama, United States | Recruiting |
| Southern Cancer Center, PC | Mobile, Alabama, United States | Recruiting |
| Banner Gateway Medical Center | Gilbert, Arizona, United States | Not Yet Recruiting |
| Banner MD Anderson Cancer Center | Gilbert, Arizona, United States | Not Yet Recruiting |
| Los Angeles Cancer Network - Anaheim | Anaheim, California, United States | Recruiting |
| City of Hope National Medical Center | Duarte, California, United States | Not Yet Recruiting |
| Los Angeles Cancer Network | Fountain Valley, California, United States | Recruiting |
| Los Angeles Hematology Oncology Medical Group | Glendale, California, United States | Recruiting |
| City of Hope at Irvine Lennar | Irvine, California, United States | Not Yet Recruiting |
| Los Angeles Cancer Network | Los Angeles, California, United States | Recruiting |
| Valkyrie Clinical Trials | Los Angeles, California, United States | Recruiting |
+ 154 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06966453